Dr. Said Dermime

Dr Said Dermime graduated with BSc. Degree in Biological Sciences from the University of Constantine, Algeria in 1985. He then received his MSc and PhD degrees in immunology from Salford University, Manchester, UK in 1987 and 1992 respectively. After that, he joined the National Cancer Institute, Milan, Italy for a period of 2 years as postdoctoral fellow and the NHLBI, NIH, Bethesda, USA, for another 2 years fellowship under an NIH Fogarty International Award. To gain industrial experience, he worked at PPL Therapeutics Limited, London, UK, and COBRA Therapeutics Ltd., UK for a period of 2 years. Dr Dermime was appointed in 1998 at the Paterson Institute for Cancer Research, Manchester, UK, as a lymphoma-cancer-vaccine Team Leader for 4 years. Subsequently, he established and led the Tumor Immunology Section at King Faisal Specialist Hospital & Research Centre, Riyadh, KSA, for a period of 6 years as a senior scientist. Dr Dermime joined after that the Dasman Diabetes Institute in Kuwait in 2008 to establish and lead the department of Biomedical Research and to head the Immunology & Innovative Cell Therapy Unit. In December 2012, he joined King Fahad Specialist Hospital in Dammam, Saudi Arabia to establish the Biomedical Research Facility and to head the Immunology & Innovative Cell therapy Program. Recently, he was recruited by the National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation to establish and Lead the Translational Cancer Research Facility.